The seasonal influenza [flu] vaccine is available for priority groups through their doctor or the Flu Express,” the ...
1d
Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...
In addition to trivalent inactivated influenza vaccines or trivalent recombinant influenza vaccine, the ACIP now recommends high-dose inactivated influenza vaccine (Fluzone High-Dose) or ...
The pandemic influenza vaccines business is even more unpredictable and depends almost exclusively on government stockpiling and supply contracts. A re-emerging focus for vaccine players ...
The combination candidate consists of Pfizer’s mRNA-based influenza vaccine candidate with the companies’ licensed COVID-19 vaccine. The Phase 3 trial measured two primary immunogenicity ...
This week on Pipeline Moves, we kick off by looking at a Phase I/II trial completion by Moderna of its pandemic influenza vaccine off the back of a government grant. Meanwhile, an investigator-led ...
Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study ...
GSK plc announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal influenza vaccine programme. The trial studied a range of mRNA formulations in older and younger ...
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback